The term bronchitis refers to inflammation of the major air passageways in the lungs, the bronchi. There are two principal types of bronchitis: acute bronchitis and chronic bronchitis. The latter is closely related to emphysema and is discussed in the article Chronic Obstructive Pulmonary Disease (COPD). Acute bronchitis, the subject of this article, is a condition that frequently develops during the course of a common cold. Symptoms may include cough (dry or productive), sensation of heaviness in the chest, and difficulty breathing.
In recent years, it has become clear that, in many cases, symptoms of bronchitis represent temporary asthma brought on by a respiratory infection. For this reason, anti-asthma drugs are now commonly a major component of treatment. Antibiotics may be used as well.
Principal Proposed Treatments
Essential Oil Monoterpenes
Aromatic essential oils, such as eucalyptus oil and peppermint oil (menthol), have a long history of use as inhalation treatments for respiratory infections. Because the supporting evidence for such treatments is quite weak, they are discussed below in Other Proposed Treatments. Considerably better evidence supports the use of certain essential oils when taken by mouth.
One combination of essential oils has been extensively evaluated as a treatment for respiratory problems. This mixture, called essential oil monoterpenes, consists of cineole from eucalyptus, d-limonene from citrus fruit, and alpha-pinene from pine. Numerous double-blind, placebo-controlled trials, many of substantial size, indicate that essential oil monoterpenes can aid recovery from sinusitis, bronchitis, and other respiratory conditions.1-7
One large study evaluated the effectiveness of essential oil monoterpenes for acute bronchitis. In this 2-week, double-blind, placebo-controlled trial of 676 people with acute bronchitis, participants received either placebo, essential oil monoterpenes, or one of two antibiotics.5 The results indicate that the essential oil mixture was significantly more effective than placebo and at least as effective as antibiotic therapy.
For more information, including dosage and safety issues, see the full Essential Oil Monoterpene article.
An alcohol extract made from the herb Pelargonium sidoides has become popular in Germany as a treatment for various respiratory problems. In one double-blind, placebo-controlled study, 468 adults with recent onset of acute bronchitis were given either placebo or a standard alcohol extract of Pelargonium sidoides 3 times daily for a week.13 The results showed a significantly greater improvement in symptoms in the treatment group as compared to the placebo group. On average, participants who received the real treatment were able to return to work 2 days earlier than those given placebo. Benefits were also seen in two other studies enrolling a total of about 350 people.14-15 When researchers pooled the results of 4 well-designed, placebo-controlled trials, they found that a standardized extract of Pelargonium performed significantly better than placebo at reducing the symptoms of bronchitis by the seventh day of treatment.18
For more information, including dosage and safety issues, see the full Pelargonium sidoides article.
Other Proposed Treatments for Acute Bronchitis TOP
A large (361-participant) double-blind, placebo-controlled study found evidence that use of a standardized combination of thyme and primrose root extract enhanced recovery from acute bronchitis.17 Symptoms improved rapidly in both groups, but improvement was faster and the response rates were higher for the thyme-primrose combination compared to placebo.
One double-blind, placebo-controlled study found that use of 200 mg per day of vitamin C enhanced recovery among 57 elderly patients hospitalized for respiratory conditions.8 Researchers have also studied the possible role of vitamin A in preventing and treating respiratory tract infections. A review of 10 trials involving over 33,000 children under age 7 years found that, in the majority of cases, vitamin A did not reduce the incidence of infection or symptoms in young children.19 In two of the studies, vitamin A was beneficial for undernourished children. However, children with adequate nutrition actually faired worse.
As mentioned above, inhaled essential oils have a long, traditional use for respiratory infections. However, while there is some preliminary scientific support for such treatments,9-12 it is still far too weak to rely upon.
It is widely believed by many proponents of alternative medicine that cow’s milk and related dairy products increase mucus in the lungs and sinuses, and should therefore be avoided by people with bronchitis problems. However, there has not been sufficient scientific investigation into this belief to either confirm or deny it.
Because acute bronchitis tends to develop during the course of a common cold, all of the natural treatments used to prevent or treat colds are worth considering. See the Common Cold article for detailed information on these options. In addition, because bronchitis is often a form of temporary asthma, the treatments discussed in the Asthma article are worth considering, as well.
References[ + ]
1. Sengespeik HC, Zimmermann T, Peiske C, et al. Myrtol standardized in the treatment of acute and chronic respiratory infections in children. A multicenter post-marketing surveillance study [in German; English abstract]. Arzneimittelforschung. 1998;48:990-994.
2. Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis—results of a double-blind, randomized multicenter study compared with placebo [in German; English abstract]. Laryngorhinootologie. 1997;76:23-27.
3. Behrbohm H, Kaschke O, Sydow K. Effect of the phytogenic secretolytic drug Gelomyrtol forte on mucociliary clearance of the maxillary sinus [in German; English abstract]. Laryngorhinootologie. 1995;74:733-737.
4. Meister R, Wittig T, Beuscher N, et al. Efficacy and tolerability of Myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators. Arzneimittelforschung. 1999;49:351-358.
5. Matthys H, de Mey C, Carls C, et al. Efficacy and tolerability of Myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung. 2000;50:700-711.
6. Ulmer WT, Schott D. Chronic obstructive bronchitis. Effect of Gelomyrtol forte in a placebo-controlled double-blind study [in German; English abstract]. Fortschr Med. 1991;109:547-550.
7. Dorow P, Weiss T, Felix R, et al. Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease [in German; English abstract]. Arzneimittelforschung. 1987;37:1378-1381.
8. Hunt C, Chakravorty NK, Annan G, et al. The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int J Vitam Nutr Res. 1994;64:212-219.
9. European Scientific Cooperative on Phytotherapy. Menthae Piperitae Aetheroleum (peppermint oil). Exeter, UK: ESCOP, 1996-1997:1-6. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 3.
10. Morice AH, Marshall AE, Higgins KS, Grattan TJ. Effect of inhaled menthol on citric acid induced cough in normal subjects. Thorax. 1994;49:1024-1026.
11. Cohen BM, Dressler WE. Acute aromatics inhalation modifies the airways. Effects of the common cold. Respiration. 1982;43:285-293.
12. Ferley JP, Poutignat N, Zmirou D, et al. Prophylactic aromatherapy for supervening infections in patients with chronic bronchitis. Statistical evaluation conducted in clinics against a placebo. Phytotherapy Research. 1989;3:97-100.
13. Matthys H, et al. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine. 2003;10(suppl 4):7-17.
14. Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial. Explore (NY). 2006;1:437-45.
15. Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study. Curr Med Res Opin. 2007;23:323-331.
16. Goos KH, Albrecht U, Schneider B. On-going investigations on efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in children in comparison with other antibiotic treatments]. Arzneimittelforschung. 2007;57:238-246.
17. Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung. 2007;57:607-615.
18. Agbabiaka TB, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: A systematic review and meta-analysis. Phytomedicine. 2008 Jan 25.
19. Chen H, Zhuo Q, Yuan W, Wang J, Wu T. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev. 2011;(1):CD006090.
Last reviewed December 2015 by EBSCO CAM Review Board
Last Updated: 12/15/2015
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.